Moleculin Biotech, Inc. was duly registered on 2024-01-13 as a Foreign Profit Corporation, with its principal office located at 5300 MEMORIAL DR STE 950, HOUSTON, TX, 77007-8274, UNITED STATES. The company falls under the classification of North American Industry Classification System (NAICS) code 11, which pertains to Other Services, MOLECULIN BIOTECH, INC. IS A PHASE 2 CLINICAL-STAGE PHARMACEUTICAL COMPANY, ORGANIZED AS A DELAWARE CORPORATION IN JULY 2015, WITH CLINICAL PROGRAMS FOR HARD-TO-TREAT CANCERS AND VIRUSES. THE COMPANY HAS THREE CORE TECHNOLOGIES, EACH OF WHICH HAVE HAD ONE OR MORE DRUGS SUCCESSFULLY COMPLETE A PHASE 1 CLINICAL TRIAL, BASED SUBSTANTIALLY ON DISCOVERIES MADE AT AND LICENSED FROM THE UNIVERSITY OF TEXAS SYSTEM ON BEHALF OF THE MD ANDERSON CANCER CENTER (MD ANDERSON) IN HOUSTON, TEXAS. Lindsey Baronie is the appointed agent of the company. Presently, the business record indicates an Active status.
MOLECULIN BIOTECH, INC. has been operational for a period of 10 months, and 12 days.
Name | Title | Address |
---|---|---|
ROBERT GEORGE | Governor | NONE |